Clinical Trial Design in the Era of AI

Clinical trials are expensive, slow, and risky. AI promises to improve study planning, patient recruitment, endpoint selection, and evidence review, while also helping teamsextract and summarize complex clinical data. But in regulated healthcare environments, reliability is critical. In this episode, Ome Ogbru, CEO of AINGENS, examines how AI can support clinical trial workflows, why hallucinations and fabricated citations create compliance risks, and how evidence-grounded systems with human oversight may help sponsors and medicalteams use AI more safely.